IPOPI welcomes the Commission’s proposal for a Regulation on Substances of Human Origin
The International Patient Organisation for Primary Immunodeficiencies (IPOPI) welcomes the European Commission proposal for a Regulation on standards of quality and safety for substances of human origin (SoHO) intended for human application published in July 2022. IPOPI is pleased that this proposal effectively provides: recognition of the importance of patient safety and the need for […]